Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial
CINCINNATI, July 4, 2025 /PRNewswire/ — During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus invading the nasal tissues of its victims, then causing millions of deaths by spreading through the body and robbing the sickest people of their ability to breathe. While the traditional way to
Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial Read Post »
Press





